These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16334365)

  • 1. Spin cycles. Healthcare marketing-communications efforts have taken on increasing strategic importance.
    Romano M
    Mod Healthc; 2005 Nov; 35(47):28-30. PubMed ID: 16334365
    [No Abstract]   [Full Text] [Related]  

  • 2. The naming game. Tyco Healthcare taking on a new moniker; is it an effort to ditch the parents?
    Romano M
    Mod Healthc; 2007 Feb; 37(9):46, 48. PubMed ID: 17348388
    [No Abstract]   [Full Text] [Related]  

  • 3. Withdrawal syndrome.
    Nat Med; 2004 Nov; 10(11):1143. PubMed ID: 15516887
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug lawsuits building. Merck, Pfizer facing charges of misrepresentation.
    Benko LB
    Mod Healthc; 2006 Apr; 36(15):16. PubMed ID: 16669517
    [No Abstract]   [Full Text] [Related]  

  • 5. The brave new world of healthcare e-commerce.
    Hirsch R
    J Cardiovasc Manag; 1999; 10(3):13-4. PubMed ID: 10557912
    [No Abstract]   [Full Text] [Related]  

  • 6. [Introductory overview article: internationalization of the health care industry].
    von Bandemer S; Blank W; Büchel D
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(8):607-15. PubMed ID: 22142884
    [No Abstract]   [Full Text] [Related]  

  • 7. Blizzard deals. In a sure sign of a robust industry, companies recently have gotten in the spirit to merge and acquire.
    Galloro V
    Mod Healthc; 2004 Dec; 34(50):6-7, 1. PubMed ID: 15631144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everybody's doing it. With the U.S. economy limping along, the unlikeliest marketers are trying to claim a niche in healthcare.
    Becker C
    Mod Healthc; 2003 May; 33(18):4-5, 12, 1. PubMed ID: 12776664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merck's recall of rofecoxib--a strategic perspective.
    Oberholzer-Gee F; Inamdar SN
    N Engl J Med; 2004 Nov; 351(21):2147-9. PubMed ID: 15548771
    [No Abstract]   [Full Text] [Related]  

  • 10. Market is ripe for hospitals to define and determine their futures.
    Pavia L
    Health Care Strateg Manage; 2001 Aug; 19(8):13-4. PubMed ID: 11507823
    [No Abstract]   [Full Text] [Related]  

  • 11. A core strategy--developing a brand. A health care organization that builds strong brand loyalty will ensure its position for the future.
    Miller DW
    Health Forum J; 2001; 44(1):36-8. PubMed ID: 11225557
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigation.
    Zalesky CD
    J Health Law; 2006; 39(2):235-64. PubMed ID: 17002233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vioxx doctors wooed by Merck are now its foes.
    Tesoriero HW
    Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharma goes to the laundry: Public relations and the business of medical education.
    Elliott C
    Hastings Cent Rep; 2004; 34(5):18-23. PubMed ID: 15553394
    [No Abstract]   [Full Text] [Related]  

  • 15. Competition: a social marketer's friend or foe?
    Wayman JJ; Beall T; Thackeray R; Brown KR
    Health Promot Pract; 2007 Apr; 8(2):134-9. PubMed ID: 17384404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trust fundamentals. Can healthcare be trusted, and can marketers influence the level of trust in their organizations?
    Gausz-Mandelberg C
    Mark Health Serv; 2006; 26(2):14-9. PubMed ID: 16827501
    [No Abstract]   [Full Text] [Related]  

  • 17. Marketplace. How U.S. hospitals are luring private-pay patients from abroad.
    Moskowitz DB
    Med Health; 1999 Jan; 53(3):suppl 1-2. PubMed ID: 10339137
    [No Abstract]   [Full Text] [Related]  

  • 18. Corporate strategy. Keeping up with the times.
    Goedert J
    Health Data Manag; 2008 Nov; 16(11):62. PubMed ID: 19024706
    [No Abstract]   [Full Text] [Related]  

  • 19. Former pharma pitchman: beware of new drugs. An industry insider advises considering the older options if you need a prescription. Interview by Sarah Baldauf.
    Nesi T
    US News World Rep; 2008 Nov 3-10; 145(10):64. PubMed ID: 18998444
    [No Abstract]   [Full Text] [Related]  

  • 20. International patients: a different market with different security needs.
    Hosp Secur Saf Manage; 1998 Sep; 19(5):5-9. PubMed ID: 10186155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.